The PSL Alliance

EpitoGenx Ltd using AI models will offer in silico solutions, validated in vitro and applied to create prototype clinical products using EpitoGen® Technology. Products developed using this technology are compatible with gold standard lab-based and point-of-care applications (i.e., ELISA, LFA, microfluidics), making them affordable and user friendly.